1. Home
  2. BIO vs LSCC Comparison

BIO vs LSCC Comparison

Compare BIO & LSCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • LSCC
  • Stock Information
  • Founded
  • BIO 1952
  • LSCC 1983
  • Country
  • BIO United States
  • LSCC United States
  • Employees
  • BIO N/A
  • LSCC N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • LSCC Semiconductors
  • Sector
  • BIO Industrials
  • LSCC Technology
  • Exchange
  • BIO Nasdaq
  • LSCC Nasdaq
  • Market Cap
  • BIO 9.1B
  • LSCC 8.0B
  • IPO Year
  • BIO N/A
  • LSCC 1989
  • Fundamental
  • Price
  • BIO $327.15
  • LSCC $57.87
  • Analyst Decision
  • BIO Strong Buy
  • LSCC Strong Buy
  • Analyst Count
  • BIO 4
  • LSCC 12
  • Target Price
  • BIO $414.00
  • LSCC $62.83
  • AVG Volume (30 Days)
  • BIO 203.8K
  • LSCC 2.1M
  • Earning Date
  • BIO 02-13-2025
  • LSCC 02-10-2025
  • Dividend Yield
  • BIO N/A
  • LSCC N/A
  • EPS Growth
  • BIO N/A
  • LSCC N/A
  • EPS
  • BIO N/A
  • LSCC 1.02
  • Revenue
  • BIO $2,580,209,000.00
  • LSCC $562,578,000.00
  • Revenue This Year
  • BIO N/A
  • LSCC N/A
  • Revenue Next Year
  • BIO $2.92
  • LSCC $2.29
  • P/E Ratio
  • BIO N/A
  • LSCC $56.49
  • Revenue Growth
  • BIO N/A
  • LSCC N/A
  • 52 Week Low
  • BIO $262.12
  • LSCC $40.65
  • 52 Week High
  • BIO $387.99
  • LSCC $85.69
  • Technical
  • Relative Strength Index (RSI)
  • BIO 44.03
  • LSCC 50.05
  • Support Level
  • BIO $318.27
  • LSCC $57.20
  • Resistance Level
  • BIO $351.08
  • LSCC $64.69
  • Average True Range (ATR)
  • BIO 11.74
  • LSCC 2.62
  • MACD
  • BIO -0.86
  • LSCC -0.40
  • Stochastic Oscillator
  • BIO 27.06
  • LSCC 12.00

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia.

Share on Social Networks: